Antiepileptic drug combinations—Have newer agents altered clinical outcomes?
Authors:
- Murray ForsythMFMurray Forsyth
- Kevin KellyKKKevin Kelly
- Martin J. BrodieMBMartin J. Brodie
- 1 February 2012
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 98 (2-3) , 194-198
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Combining antiepileptic drugs—Rational polytherapy?Seizure: European Journal of Epilepsy, 2011
- Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemmaEpilepsia, 2011
- Antiepileptic drug therapy the story so farSeizure: European Journal of Epilepsy, 2010
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical MechanismsEpilepsia, 2005
- The epidemiology of epilepsy revisitedCurrent Opinion in Neurology, 2003
- Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence ReviewedEpilepsia, 2000
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- The Efficacy of Valproate‐Lamotrigine Comedication in Refractory Complex Partial Seizures: Evidence for a Pharmacodynamic InteractionEpilepsia, 1999
- Lamotrigine substitution study: evidence for synergism with sodium valproate?Epilepsy Research, 1997